Cargando…
Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation
The transcriptional repressor called parkin interacting substrate (PARIS; ZNF746) was initially identified as a novel co-substrate of parkin and PINK1 that leads to Parkinson’s disease (PD) by disrupting mitochondrial biogenesis through peroxisome proliferator-activated receptor gamma (PPARγ) coacti...
Autores principales: | Yazar, Volkan, Kang, Sung-Ung, Ha, Shinwon, Dawson, Valina L., Dawson, Ted M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563805/ https://www.ncbi.nlm.nih.gov/pubmed/34728675 http://dx.doi.org/10.1038/s41598-021-00858-7 |
Ejemplares similares
-
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
por: Yazar, Volkan, et al.
Publicado: (2023) -
Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
por: Yin, Xiling, et al.
Publicado: (2021) -
PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
por: Pirooznia, Sheila K., et al.
Publicado: (2020) -
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014) -
Waiting for PARIS—A Biological Target in Search of a Drug: PARIS farnesylation: Considerations in addressing a new biological target for neuroprotection in patients with Parkinson’s disease
por: Wyse, Richard K., et al.
Publicado: (2022)